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Abstract Blood separation is a strategic preliminary step in preparation to on-chip biological analysis. Two 
microfluidic devices for on-chip blood separation are presented. Both devices will be integrated to form the 
separation module of a Lab on Chip for non-invasive prenatal diagnosis. In the first device, a blood plasma 
separator, the separation of blood cells from plasma is made possible in microchannels by bio-physical 
effects such as an axial migration effect  and Zweifach-Fung bifurcation law. Behaviour of mussel and human 
blood suspensions were studied alongside the effect  of different geometries. The second device aims to 
separate fetal nucleated red blood cells based on their magnetic susceptibility. Biocompatible materials are 
used in the manufacturing of both devices.
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1. Introduction
 The ability to accurately detect and separate 
various biological particles from a wide variety 
of samples including blood, urine, and saliva is 
an essential process in clinical and research 
activities. Analysis of a pure cell population 
from a complex biological system or blood 
plasma can lead to a greater understanding of 
disease pathology and help  in the development 
of new therapeutics. Microfluidics permits the 
analysis of a few microlitres of biological 
samples, and avoids the painful blood 
extraction of several dozens of millilitres. 
Centrifugation and filtration are the two 
conventional techniques for blood separation in 
laboratories. Both methods are time-
consuming, relatively  expensive and might 
damage cells if not  used carefully (Sallam,
1984). In light of the disadvantages outlined 
above and the benefits that  microscale 
techniques can provide in terms of volume of 
blood extracted, response time and portability, 
it is therefore unsurprising that the alternative 
blood separation on-chip  has gained increasing 
interest over the last  few years. Different types 
of force available at the microscale have been 
used to separate blood on-chip. Such forces are 
electrical, magnetic and acoustic (Pamme, 
2007; Kersaudy-Kerhoas, 2008). This paper 
describes the fabrication and testing of two 
microfluidic devices that are to form the 
separation module of a lab-on-a-chip  for non-
invasive prenatal diagnosis (NIPD) as shown in 
Figure 1.  The microsystem envisaged will be a 
disposable cartridge with integrated modules 
for separation, preparation and analysis of fetal 
genetic material from maternal whole blood.
Figure 1: Lab on Chip flow diagram for NIPD. This 
diagram shows the different steps of a NPID system 
from the patient to the results. Nucleated red blood cell 
(nRBC) target fetal cell for analysis.  This paper deals 
with the first two steps in the separation part. 
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2.Blood Plasma Separator
  Firstly plasma is removed from maternal 
blood to be analysed for cell free fetal nucleic 
acids and screened for pregnancy indicator 
proteins. For example low levels of pregnancy 
associated plasma protein A (PAPP-A) are 
associated with certain fetal chromosome 
abnormalities (Cunniff, 2004). Removing the 
plasma at this stage reduces the levels of blood 
inhibitors such as immunoglobulin G (IgG) 
which can affect downstream analysis (Al-
Soud et al., 2000).  
 
2.1 Theory and Design.
 Separation techniques using only 
hydrodynamic forces, channels geometries and 
bio-physical effects have lately  been 
developed, based on preliminary work on 
microcirculation (Fung, 2004). 
The design of an optimised blood plasma 
separator is based on an original in-house 
device (Kersaudy-Kerhoas, 2008). The use of 
microchannels ensures laminar flow and the 
presence of a particle-free layer. Constrictions 
inducing a high-shear stress zone pulling the 
particles even more centrally  are integrated 
along the main channel (Faivre, 2006); four 
bifurcation channels are placed on each side of 
the main channel after each constriction. Red 
blood cells exhibit a specific behaviour in 
bifurcations. Fung demonstrated that cells at a 
bifurcation have a tendency to travel to the 
highest flow rate daughter channel, providing 
that the flow rate ratio is at least 2.5:1 and the 
dimensions of the cells are comparable to the 
channel diameter. This effect is sometimes 
referred to as the Zweifach-Fung bifurcation 
law. Its origin is found in the asymmetrical 
distribution of pressure and shear forces on the 
cell at the bifurcation, pulling it  to the channel 
with the highest flow. 
The overall aim of the system is to reach 
optimum purity efficiency, Ep, defined as:
                             (1)
where cp and cf are the number of events per 
mL in the plasma collection outlet and in the 
feed inlet, respectively.
 As shown in Figure 2, the external 
connection consists of only one inlet to 
introduce the diluted blood and three outlets. 
One of these outlets collects the cells and the 
other two collect the plasma. 
Figure 2: Optimised design of the blood plasma 
separator filled with a blue dye.
2.2 Fabrication and Testing.
Epigem Ltd (Redcar, UK), our industrial 
partner, has manufactured the chips using a 
standard lithography process. A PMMA lid and 
base layers are produced in order to create a 
bonded chip  laminate. On top  of the base layer 
is a further layer of SU8, into which are 
defined by photolithography the channel 
features. Further processing is carried out in 
the clean room following well defined 
procedures. A photograph of the fabricated 
microfluidic chip is shown in Fig. 3
 Mussel blood was used in preliminary 
testing of the device as it was easily obtained 
and the cells have relative sizes comparable to 
human blood cells. Human blood was collected 
from a healthy volunteer by finger prick using 
a sterile disposable lancet (Accu-check, Roche, 
Switzerland).The collected blood was 
suspended in 1mL of anticoagulant solution 
composed of Phosphate Buffered Saline (PBS) 
1x and 10µL of ethylene diamine tetraacetic 
acid trypsin (EDTA-trypsin) (0.05M, Gibco). 
200µL of the sample collections (cell and 
plasma) were screened using a flow cytometer 
(FC) (Partec CyFlow® SL, Germany). Flow 
cytometry  allows accurate analysis of cell and 
particle populations.  
 The graph shown on Figure 3 is obtained 
from the FC results on the original design 
pictured at the top of Figure 3 (with 20 
bifurcations on each side of the channel and 
only one constriction) and shows the number 
of events counted by the FC versus the size of 
the particle. The results, shows a purity 
efficiency of 56.6% at a flow rate of 20mL/hr. 
Figure 3: Flow Cytometry results. Graph of number of 
events in the feed, plasma and cell collection,  versus the 
size of the particles in the original design (Kersaudy-
Kerhoas, 2008).
The optimised design featured on Figure 2 is 
expected to give higher purity efficiencies at 
lower flow rates.
3. Micromagnetic Separator.
  Magnetic separation of a pure cell population 
from a heterogenous starting sample is a well 
established technique in biomedical research. 
Superparamagnetic beads are commonly 
labelled with antibodies to specific receptors 
expressed on the surface of target cells. In most 
cases the use of beads is necessary in order to 
achieve magnetic separation. Recently 
however separation strategies have been 
investigated that do not require the use of 
expensive cell labels.  One such method is 
magnetophoresis, which refers to the 
separation of biological cells based on their 
intrinsic magnetic properties (Zborowski, 
2003). The use of magnetophoresis to separate 
blood has many advantages which include: 
low-cost manufacturing, simple structure, non-
contact separation technique, hydraulic nature 
of magnetic field. Macroscale magnetic 
separators have had limited success as the 
generated fluxes are too small to have an effect 
on non-labelled biological cells (Han & 
Frazier, 2006; Pamme, 2006). To overcome this 
issue a micromagnetic separator is proposed in 
this paper for the separation of fetal nuleated 
red blood cells from maternal blood.
3.1 Theory and Design.
  Most biological cells are diamagnetic by 
nature, however, deoxygenated red blood cells 
(RBCs) become paramagnetic due to the 
chemical interactions between the iron atom, 
the heme group and the globin domain of 
hemoglobin. In oxygenated hemoglobin the 
chemical bonds are covalent but in 
deoxygenated hemoglobin the bonds are ionic 
with 4 or 5 unpaired electrons present making 
it paramagnetic (Zborowski, 2003; Pauling, 
2003). The magnetic susceptibility of 
deoxygenated RBCs in plasma has been noted 
in the literature to be approximately 3.9 10-6 
(SI), which is much larger than other blood 
cells (Han & Frazier, 2006). 
  The proposed micromagnetic separator 
consists of a single microchannel, 100μm wide, 
with one inlet and 3 oulets. Electroplated 
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permalloy Ni80Fe20 elements are positioned in 
close proximity to the channel wall (Fig 4a). 
The fluidic channel has 2mm circular 
reservoirs for attachment of fluidic connectors. 
The external magnetic flux is provided by 
permanent neodymium iron boron (NdFeB) 
magnet (Fig 4b). The external magnetic flux 
provided by the permanent magnet magnetises 
the NiFe elements, creating a non-uniform 
field, which gives rise to a magnetic force on 
the deoxygenated blood as it flows through the 
microchannel (Fig 4c). Therefore, the magnetic 
forces in combination with the microchannel 
geometry allow blood cell separation. 
3.2 Fabrication and Testing.
   The micromagnetic separator is fabricated 
through micromachining of the photoresists 
AZ9260 and SU8 on a 50µm thick Kapton 
polyimide substrate. A glass wafer is used as a 
carrier substrate for the polyimide. Firstly, seed 
layers of titanium and nickel are deposited onto 
the polyimide substrate, using electron beam 
e v a p o r a t i o n , t o a l l o w f o r u n i f o r m 
electroplating across the surface of the 
polyimide. The positive photoresist AZ9260 is 
spin coated and baked in 4 layers to achieve 
the required magnetic element height of 
100µm. AZ 9260 is patterned with UV light 
with a Tamarac mask aligner at  an exposure 
dose of 2000mJ/cm2 followed by 20 minutes of 
development in AZ developer. The Ni80Fe20 
permalloy is then DC electroplated. Once done, 
the AZ photoresist is stripped with acetone and 
the seed layer is etched. 
 The microfluidic channel is fabricated with the 
negative photoresist SU8-50 through UV 
photolithography. A layer of 100µm thick of 
SU8 photoresist is spin coated on top of the 
electroplated elements. A soft bake process at a
temperature of 65o C for 2 minutes and than 15 
minutes at 95oC is performed followed by 
sufficient cooling and relaxation time intervals.
UV lithography  with a Tamarac mask aligner is 
performed at an exposure dose of 960mJ/cm2 
with an I-line filter. The wafer is then post 
baked at 55oC for 2 minutes and after sufficient 
relaxation time interval developed in EC 
solvent using a magnetic stirrer system for 
about 15 minutes. To seal the microchannels, 
SU8-50 is spun onto a similar polymer 
substrate and soft  baked at 65oC for 2 minutes 
and 95oC for 5 minutes to form the cover for 
the microchannels.
Figure 4: (a) Top view of the micromagnetic separator. 
(b) Cross-section in the (zx)  plane of the 3D model. 
showing permanent magnet position to chip (c) The Y 
component of simulated magnetic field in the channel. 
The substrate with the microfluidic channel is 
then bonded with the cover substrate. Exposure 
of the bonded structure is done through the 
backside of the adhesive layer. This is followed 
by a post exposure bake to complete the cross-
linking at a temperature of 55oC and with a 
force of 2Kgf for two minutes. The bonded 
substrates are then diced to form individual 
microfluidic channel packages of 40mm x 
30mm. Figure 5 shows SU8 microchannels 
before bonding, auxiliary structures such as 
moats and stress relief lines are incorporated 
into the design to help  with bonding and reduce 
cracking. PDMS connectors are then glued to 
the reservoirs at the end of the microfluidic 
channels and attached to a low velocity pump. 
The functionality  of the prototype device will 
be tested using human blood and goose blood 
as models for fetal cells. 
Figure 5: (a) Microchannels fabricated in SU8 (b) SEM 
image of SU8 channels
4. Conclusion and Future Work.
  This paper has described the fabrication and 
testing of two microfluidic devices that will 
form the separation module of a lab-on-a-chip 
for non-invasive prenatal diagnosis. The first 
module, a blood plasma separator, has 
demonstrated that cells can be separated from 
plasma at  high flow rate using biophysical 
effects. Experimental results show that the 
separation efficiencies obtained are in good 
agreement with previous studies, and with a 
better plasma yield. The second module, a 
micromagnetic separator, has shown promising 
and encouraging results in initial proof of 
experiments and simulations. Both chips have 
b e e n m a n u f a c t u r e d w i t h l o w - c o s t 
biocompatible materials. 
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